Journal Title：Ejnmmi Research

EJNMMI Research publishes new basic, translational and clinical research in the field of nuclear medicine and molecular imaging. Regular features include original research articles, rapid communication of preliminary data on innovative research, interesting case reports, editorials, and letters to the editor. Educational articles on basic sciences, fundamental aspects and controversy related to pre-clinical and clinical research or ethical aspects of research are also welcome. Timely reviews provide updates on current applications, issues in imaging research and translational aspects of nuclear medicine and molecular imaging technologies.

The main emphasis is placed on the development of targeted imaging with radiopharmaceuticals within the broader context of molecular probes to enhance understanding and characterisation of the complex biological processes underlying disease and to develop, test and guide new treatment modalities, including radionuclide therapy.

EJNMMI Research 發(fā)表核醫(yī)學和分子成像領(lǐng)域的新基礎(chǔ)、轉(zhuǎn)化和臨床研究。常規(guī)專題包括原創(chuàng)研究文章、創(chuàng)新研究初步數(shù)據(jù)的快速交流、有趣的病例報告、社論和致編輯的信。也歡迎有關(guān)基礎(chǔ)科學、與臨床前和臨床研究或研究倫理方面相關(guān)的基本方面和爭議的教育性文章。及時的評論提供有關(guān)當前應(yīng)用、成像研究問題以及核醫(yī)學和分子成像技術(shù)的轉(zhuǎn)化方面的最新信息。

主要重點是在分子探針的更廣泛背景下使用放射性藥物進行靶向成像的開發(fā)，以增強對疾病背后復(fù)雜生物過程的理解和表征，并開發(fā)、測試和指導(dǎo)新的治療方式，包括放射性核素治療。

Ejnmmi Research創(chuàng)刊于2011年，由Springer Berlin Heidelberg出版商出版，收稿方向涵蓋RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING&nb全領(lǐng)域，此刊是中等級別的SCI期刊，所以過審相對來講不是特別難，但是該刊專業(yè)認可度不錯，仍然是一本值得選擇的SCI期刊 。平均審稿速度 13 Weeks ，影響因子指數(shù)3.1，該期刊近期沒有被列入國際期刊預(yù)警名單，廣大學者值得一試。